共 50 条
- [1] Plasma and lymph pharmacokinetics of recombinant human interleukin-2 and polyethylene glycol-modified interleukin-2 in pigs JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (01): : 248 - 259
- [2] REEVALUATION OF THE SUPERIORITY OF POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 OVER REGULAR RECOMBINANT INTERLEUKIN-2 JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (07): : 641 - 645
- [3] Polyethylene glycol-modified interleukin-2 and thymosin alpha(1) in human immunodeficiency virus type 1 infection JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04): : 1005 - 1008
- [5] A HIGHLY ENHANCED THROMBOPOIETIC ACTIVITY BY MONOMETHOXY POLYETHYLENE GLYCOL-MODIFIED RECOMBINANT HUMAN INTERLEUKIN-6 JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 124 (04): : 529 - 536
- [6] Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: A randomized, controlled, multicenter study JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04): : 992 - 999
- [8] Photodynamic effect of polyethylene glycol-modified fullerene on tumor JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (11): : 1108 - 1116
- [10] ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2 EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1738 - 1738